Definitive Diagnostics, Inc.
Definitive Diagnostics develops advanced, protein-based blood tests for earlier cancer detection. The platform utilizes patented biomarker pattern measurement, enhanced by AI, to improve diagnostic reliability and affordability. This technology aims to accelerate timely diagnosis and reduce unnecessary waste from false test results for millions of patients.
- Biotechnology
- Healthcare Technology
Updated 7 months ago
Funding
Raised to date
$100KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Definitive Diagnostics develops advanced, protein-based blood tests for earlier cancer detection. The platform utilizes patented biomarker pattern measurement, enhanced by AI, to improve diagnostic reliability and affordability. This technology aims to accelerate timely diagnosis and reduce unnecessary waste from false test results for millions of patients.